| Degradation of hydroxylapatite, fluorapatite, and fluorhydroxyapatite coatings of dental implants in dogs L Gineste, M Gineste, X Ranz, A Ellefterion, A Guilhem, N Rouquet, ... Journal of Biomedical Materials Research: An Official Journal of The Society …, 1999 | 263 | 1999 |
| Osseointegration of macroporous calcium phosphate ceramics having a different chemical composition P Frayssinet, JL Trouillet, N Rouquet, E Azimus, A Autefage Biomaterials 14 (6), 423-429, 1993 | 255 | 1993 |
| NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy C Jin, P Frayssinet, R Pelker, D Cwirka, B Hu, A Vignery, SC Eisenbarth, ... Proceedings of the National Academy of Sciences 108 (36), 14867-14872, 2011 | 253 | 2011 |
| Importance of hydroxyapatite particles characteristics on cytokines production by human monocytes in vitro P Laquerriere, A Grandjean-Laquerriere, E Jallot, G Balossier, ... Biomaterials 24 (16), 2739-2747, 2003 | 228 | 2003 |
| Short-term implantation effects of a DCPD-based calcium phosphate cement P Frayssinet, L Gineste, P Conte, J Fages, N Rouquet Biomaterials 19 (11-12), 971-977, 1998 | 192 | 1998 |
| Bonding of hydroxyapatite-coated femoral prostheses. Histopathology of specimens from four cases DC Hardy, P Frayssinet, A Guilhem, MA Lafontaine, PE Delince The Journal of Bone & Joint Surgery British Volume 73 (5), 732-740, 1991 | 181 | 1991 |
| Use of supercritical CO2 for bone delipidation J Fages, A Marty, C Delga, JS Condoret, D Combes, P Frayssinet Biomaterials 15 (9), 650-656, 1994 | 128 | 1994 |
| Involvement of toll-like receptor 4 in the inflammatory reaction induced by hydroxyapatite particles A Grandjean-Laquerriere, O Tabary, J Jacquot, D Richard, P Frayssinet, ... Biomaterials 28 (3), 400-404, 2007 | 118 | 2007 |
| Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbits’ bone defects PH Laffargue, HF Hildebrand, M Rtaimate, P Frayssinet, JP Amoureux, ... Bone 25 (2), 55S-58S, 1999 | 117 | 1999 |
| Method for preparing an implantable composite material, resulting material, implant including said material, and kit therefor A Lerch, P Frayssinet US Patent 6,018,095, 2000 | 112 | 2000 |
| Resorption kinetics of osseous substitute: natural coral and synthetic hydroxyapatite F Braye, JL Irigaray, E Jallot, H Oudadesse, G Weber, N Deschamps, ... Biomaterials 17 (13), 1345-1350, 1996 | 112 | 1996 |
| Biological performance of a new β‐TCP/PLLA composite material for applications in spine surgery: In vitro and in vivo studies S Aunoble, D Clément, P Frayssinet, MF Harmand, JC Le Huec Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2006 | 106 | 2006 |
| Adsorption and release of insulin‐like growth factor‐I on porous tricalcium phosphate implant P Laffargue, P Fialdes, P Frayssinet, M Rtaimate, HF Hildebrand, ... Journal of Biomedical Materials Research: An Official Journal of The Society …, 2000 | 102 | 2000 |
| Viral inactivation of human bone tissue using supercritical fluid extraction B POIRIER, Y BARBIER, P FRAYSSINET, ML JOFFRET, W MAJEWSKI, ... Asaio Journal 44 (4), 289-293, 1998 | 102 | 1998 |
| Biphasic synthetic bone substitute use in orthopaedic and trauma surgery: clinical, radiological and histological results C Schwartz, P Liss, B Jacquemaire, P Lecestre, P Frayssinet Journal of Materials Science: Materials in Medicine 10 (12), 821-825, 1999 | 94 | 1999 |
| Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation L Aresu, V Martini, F Rossi, M Vignoli, M Sampaolo, A Aricò, P Laganga, ... Veterinary and Comparative Oncology 13 (4), 348-362, 2015 | 91 | 2015 |
| Randomized, placebo-controlled, double-blinded chemoimmunotherapy clinical trial in a pet dog model of diffuse large B-cell lymphoma L Marconato, P Frayssinet, N Rouquet, S Comazzi, VF Leone, P Laganga, ... Clinical Cancer Research 20 (3), 668-677, 2014 | 89 | 2014 |
| Comparative biological properties of HA plasma-sprayed coatings having different crystallinities P Frayssinet, F Tourenne, N Rouquet, P Conte, C Delga, G Bonel Journal of materials science: materials in medicine 5 (1), 11-17, 1994 | 89 | 1994 |
| MMP-2, MMP-9 and their inhibitors TIMP-2 and TIMP-1 production by human monocytes in vitro in the presence of different forms of hydroxyapatite particles P Laquerriere, A Grandjean-Laquerriere, S Addadi-Rebbah, E Jallot, ... Biomaterials 25 (13), 2515-2524, 2004 | 85 | 2004 |
| A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and self-antigens in cancer patients DR Ciocca, P Frayssinet, FD Cuello-Carrión Cell stress & chaperones 12 (1), 33, 2007 | 68 | 2007 |
